Clinical Trial Update: A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 randomized crossover trial assessing PK, PD, and safety of GBPD002; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Blood and Blood Product Toxicity

Drugs mentioned

• GBPD002

Snippet

Sponsor: Globe Biotech Limited | Conditions: Natural Blood and Blood Product Toxicity | Phase 1, Phase 2 | Status: COMPLETED